| Reduced Risk Status: |
THIS AI HAS BEEN CLASSIFIED AS RR FOR ONE OR MORE FOOD USES.
|
| IPM Compatibility: |
PER REQUESTER: UNKNOWN IPM FIT:07/20
|
| Reasons for need: |
ANTHRACNOSE AND OTHER FLOWER/FRUIT PATHOGENS; POTENTIAL FOR LAUREL WILT CONTROL; NEEDED TO PREVENT POST-HARVEST DISEASES AND MAINTAIN FRUIT QUALITY
|
| Requesting State(s): |
PR:Robles, W* ;
|
| PCR Use Pattern: |
USE THE FONTELIS PRODUCT; MAKE 3 FOLIAR DIRECTED APPLIC OF 0.313 LB AI/A, 10-DAY INTERVAL, 0-DAY PHI; INCLUDE AN ADJUVANT; FONTELIS 200 SC AT 24 FL OZ/A (1X) AND 48 FL OZ/A (2X); 80-200 GPA: 02/22;
|
| EPA Default Residue Trials: |
3 10-4
|
| IR-4 Residue Trial Plan: |
3-2 10-3 (1 DECLINE) (IR-4 TFM APPROVED DOING REG. 13 TRIALS INSTEAD OF REG. 3 TRIALS)
|
| Residue Protocol Use Pattern: |
USE THE FONTELIS 200 SC PRODUCT (1.67 LB AI/GAL OF PENTHIOPYRAD ACTIVE INGREDIENT); MAKE 3 FOLIAR DIRECTED APPLIC OF 0.313 LB AI/A, IN 80-200 GPA, 10-DAY INTERVAL, 0-DAY PHI; ALL APPLIC SHALL INCLUDE A LABELED RATE OF AN ADJUVANT
|
| Efficacy/Crop Safety (E/CS) Data Required: |
MFG REQUESTS 3-5 GOOD EFFICACY TRIALS TO REGISTER THIS USE, INCLUDING DATA FROM AT LEAST 1 CA TRIAL:12/20
|
| E/CS Research Comments: |
IN THE 2021 PERFORMANCE PROTOCOL: EVALUATING PRODUCT PERFORMANCE ON COMMERCIAL VARIETIES SUSCEPTIBLE TO ANTHRACNOSE; TESTING 2 RATES OF FONTELIS 200 SC FUNGICIDE, 0.313 AND 0.626 LB AI/A APPLIED FOLIAR DIRECTED 3 TIMES AT 10-DAY INTERVALS, VS PRISTINE AS A STANDARD APPLIED FOLIAR DIRECTED TWICE AT A 7-DAY INTERVAL; SPRAY VOLUME IS 80-200 GPA FOR BOTH PRODUCTS, AND A NON-IONIC SURFACTANT SHOULD BE INCLUDED AT NO MORE THAN A 0.08% RATE; EVALUATE CROP INJURY AFTER EACH APPLIC AND AT TRIAL CONCLUSION; EVALUATE HARVESTED FRUIT FOR INCIDENCE AND SEVERITY OF ANTHRACNOSE; EVALUATE FOLIAR DISEASE SEVERITY BY ASSESSING PERCENTAGE OF CANOPY AFFECTED BY ANTHRACNOSE; CROP YIELD DATA ARE NOT REQUIRED; IN THE 2022 PERFORMANCE PROTOCOL, TREATMENTS AND ALL OTHER PROTOCOL DETAILS DUPLICATE WHAT WAS REQUIRED IN THE 2021 PROTOCOL; THE 2023 PERFORMANCE PROTOCOL FOR A CA TRIAL IS SIMILAR TO 2021 AND 2022 PROTOCOLS, EXCEPT DISEASE INOCULATION WILL BE NEEDED TO ENSURE ROBUST DATA; E/CS field trials are still ongoing:05/23/sb
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
GREEN:12/20
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
IS A LIKELY EXPORT COMMODITY, BUT NO KEY EXPORT MARKET NOTED; THIS USE, ALONG WITH THE ACTIVE IR-4 BANANA STUDY (PR#11307), COULD SUPPORT A SUBGROUP 24B TOLERANCE AND COVER MANY CROPS, LIKE POMEGRANATE (PR#13514) AND MANGO (PR#12997):06/20; CORTEVA SUPPORTS THIS REQUEST, AND MINIMALLY WOULD NEED RESIDUE AND CROP SAFETY DATA:08/20; EPA GREEN:12/20; All residue data has been rec'd at HQ & E/CS field trials are still ongoing:05/23/sb
|
| International Status: |
|
| Archive Location: |
|
| QA Archive: |
|